Evaluating The Safety and Efficacy of Glucostabilizer in the Management of Diabetic Ketoacidosis

NYU Langone Health | Endocrine practice

GlucoStabilizer can be successfully used in the management of DKA with the avoidance of hypoglycemia. The GlucoStabilizer software-guided insulin dosing system with settings configured to the unique goals of DKA treatment was superior to ADA protocol-directed provider-guided insulin adjustment. Patients treated with GlucoStabilizer calculated doses experienced no hypoglycemia and required less insulin as compared to those managed with ADA protocol-directed provider-guided insulin adjustment.

Click below to download.